• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症恶病质与治疗毒性。

Cancer cachexia and treatment toxicity.

作者信息

Chowdhry Shilpa Mukunda, Chowdhry Varun Kumar

机构信息

Department of Geriatrics and Palliative Medicine, State University of New York at Buffalo.

Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.

出版信息

Curr Opin Support Palliat Care. 2019 Dec;13(4):292-297. doi: 10.1097/SPC.0000000000000450.

DOI:10.1097/SPC.0000000000000450
PMID:31389845
Abstract

PURPOSE OF REVIEW

Cancer cachexia is a metabolic disturbance resulting in a loss of skeletal muscle mass that is generally not reversed through traditional nutritional interventions. We review on both the impact of nutritional status on cancer treatment side effects, as well as cancer- specific outcomes.

RECENT FINDINGS

Cancer-specific cachexia and sarcopenia are associated with increased treatment-associated toxicity, and overall worse cancer-specific outcomes across all cancer types in surgical, chemotherapeutic, and radiotherapeutic populations. Despite the fact that cancer cachexia is generally thought to be irreversible, there is some evidence that nutritional intervention can be helpful.

SUMMARY

Nutritional status is an important factor to consider in determining cancer therapy. Patients with poor nutritional status should be identified prior to the initiation of therapy and be monitored judiciously.

摘要

综述目的

癌症恶病质是一种代谢紊乱,导致骨骼肌质量丧失,通常无法通过传统营养干预措施逆转。我们将综述营养状况对癌症治疗副作用以及癌症特异性结局的影响。

最新发现

癌症特异性恶病质和肌肉减少症与治疗相关毒性增加有关,并且在手术、化疗和放疗人群中,所有癌症类型的癌症特异性结局总体上更差。尽管一般认为癌症恶病质是不可逆的,但有一些证据表明营养干预可能会有所帮助。

总结

营养状况是确定癌症治疗方案时需要考虑的重要因素。营养状况不佳的患者应在治疗开始前确定,并进行审慎监测。

相似文献

1
Cancer cachexia and treatment toxicity.癌症恶病质与治疗毒性。
Curr Opin Support Palliat Care. 2019 Dec;13(4):292-297. doi: 10.1097/SPC.0000000000000450.
2
Cancer cachexia in thoracic malignancy: a narrative review.胸部恶性肿瘤中的癌症恶病质:一篇综述
Curr Opin Support Palliat Care. 2019 Dec;13(4):316-322. doi: 10.1097/SPC.0000000000000465.
3
Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.癌症中的二十碳五烯酸可改善身体成分并调节新陈代谢。
Nutrition. 2015 Apr;31(4):549-55. doi: 10.1016/j.nut.2014.12.002. Epub 2014 Dec 12.
4
Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.恶病质是否与胃肠道癌症患者的化疗毒性相关?一项前瞻性研究。
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):445-454. doi: 10.1002/jcsm.12391. Epub 2019 Mar 28.
5
A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes.皮肤下的窗口:体成分计算机断层评估如何帮助识别肿瘤学中隐藏的消耗状况,这些状况对结果有深远影响。
Proc Nutr Soc. 2018 May;77(2):135-151. doi: 10.1017/S0029665118000046.
6
Dietetic assessment and intervention in lung cancer.肺癌的饮食评估与干预
Curr Opin Support Palliat Care. 2019 Dec;13(4):311-315. doi: 10.1097/SPC.0000000000000453.
7
From cachexia to obesity: the role of host metabolism in cancer immunotherapy.从恶病质到肥胖:宿主代谢在癌症免疫治疗中的作用。
Curr Opin Support Palliat Care. 2019 Dec;13(4):305-310. doi: 10.1097/SPC.0000000000000457.
8
Sarcopenia, Malnutrition, and Cachexia: Adapting Definitions and Terminology of Nutritional Disorders in Older People with Cancer.肌肉减少症、营养不良和恶病质:癌症老年患者营养障碍定义和术语的调整。
Nutrients. 2021 Feb 26;13(3):761. doi: 10.3390/nu13030761.
9
Impact of musculoskeletal degradation on cancer outcomes and strategies for management in clinical practice.肌肉骨骼退化对癌症结局的影响及临床实践中的管理策略。
Proc Nutr Soc. 2021 Feb;80(1):73-91. doi: 10.1017/S0029665120007855. Epub 2020 Nov 3.
10
[Nutritional Management in Cancer Chemotherapy Based on Pathophysiology of Sarcopenia].基于肌肉减少症病理生理学的癌症化疗营养管理
Gan To Kagaku Ryoho. 2020 Nov;47(11):1552-1556.

引用本文的文献

1
Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia.肿瘤-脂肪组织串扰中的细胞外囊泡:癌症恶病质的关键驱动因素和治疗靶点
Extracell Vesicles Circ Nucl Acids. 2024 Jul 23;5(3):371-396. doi: 10.20517/evcna.2024.36. eCollection 2024.
2
Development and validation of a prognostic model for cachexia in postoperative gastric cancer patients with low nutritional risk: a dual-center retrospective cohort study.低营养风险的术后胃癌患者恶病质预后模型的建立与验证:一项双中心回顾性队列研究
Surg Endosc. 2025 Jan;39(1):237-248. doi: 10.1007/s00464-024-11367-9. Epub 2024 Nov 5.
3
Association between preoperative diagnosis of sarcopenia and postoperative pneumonia in resectable esophageal squamous cell carcinoma patients: a retrospective cohort study.
可切除食管鳞状细胞癌患者术前肌肉减少症诊断与术后肺炎的关系:一项回顾性队列研究
Front Oncol. 2023 May 18;13:1144516. doi: 10.3389/fonc.2023.1144516. eCollection 2023.
4
Embracing complexity in Drosophila cancer models.拥抱果蝇癌症模型中的复杂性。
Dis Model Mech. 2022 Mar 1;15(3). doi: 10.1242/dmm.049513. Epub 2022 Mar 28.
5
The Role of Nutritional Support for Cancer Patients in Palliative Care.癌症患者姑息治疗中的营养支持作用。
Nutrients. 2021 Jan 22;13(2):306. doi: 10.3390/nu13020306.
6
Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma.基于老年营养风险指数和肌肉减少症的弥漫性大 B 细胞淋巴瘤患者的预后模型。
BMC Cancer. 2020 May 18;20(1):439. doi: 10.1186/s12885-020-06921-2.
7
Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.癌症恶病质的研究进展:受影响器官、介质和药物干预的交叉点。
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188359. doi: 10.1016/j.bbcan.2020.188359. Epub 2020 Mar 25.
8
Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review.癌症相关性恶病质的新兴治疗选择:文献综述
Ther Clin Risk Manag. 2019 Oct 29;15:1253-1266. doi: 10.2147/TCRM.S196802. eCollection 2019.